Abstract
Background: Although morbidity and mortality from coronary artery disease can be improved with a variety of pharmacologic interventions, many patients remain undertreated.
Hypothesis: This study sought to assess whether hospitalization for possible coronary artery disease would prompt initiation of appropriate lipid‐lowering therapy.
Methods: This prospective, observational study was conducted on consecutive patients with active chest pain admitted to the Emergency Department of the hospital for suspected myocardial ischemia. Elevated cholesterol, defined as low‐density lipoprotein (LDL), was > 100 mg/dl with a prior history or a new diagnosis of coronary artery disease, or an LDL > 130 mg/dl without known coronary artery disease. Data were recorded at the time of admission, discharge, and at 4‐month follow‐up.
Results: Of the patients with hyperlipidemia, 65% men and 55% women were on medication at the time of admission (p = 0.30), while at discharge, 79% men and 60% women were on treatment (p = 0.002), with similar rates of treatment at 4‐monthfollow‐up (p = 0.030). At discharge, two variables were independently associated with patients receiving lipid‐lowering therapy: age ≥ 65 years (odds ratio = 2.3; 95% confidence interval 1.2–4.5) and male gender (2.7; 15–5.0).
Conclusions: In patients hospitalized with chest pain, particularly in women, the initiation of treatment of hyperlipidemia frequently does not happen. This oversight represents a lost opportunity for making an impact on the health of this population.
Keywords: hyperlipidemia, hospital medicine
Full Text
The Full Text of this article is available as a PDF (28.9 KB).
References
- 1. Sheifer S, Escarce J, Schulman K: Race and sex differences in the management of coronary artery disease. Am Heart J 2000; 139: 848–857 [DOI] [PubMed] [Google Scholar]
- 2. Chandra N, Ziegelstein R, Rogers W, Tiefenbrunn AJ, Gore JM, French WJ, Rubison M: Observations of the treatment of women in the United States with myocardial infarction: A report from the National Registry of Myocardial Infarction. Arch Intern Med 1998; 158: 981–988 [DOI] [PubMed] [Google Scholar]
- 3. Rich SE, Shah J, Rich DS, Shah R, Rich MW: Effects of age, sex and race, diagnosis‐related group, and hospital setting on lipid management in patients with coronary artery disease. Am J Cardiol 2000; 86: 328–330 [DOI] [PubMed] [Google Scholar]
- 4. Scandinavian Simvastatin Survival Study Group : Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389 [PubMed] [Google Scholar]
- 5. Sacks FM, Pfeffer MA, Moyé LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E: Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996; 335: 1001–1009 [DOI] [PubMed] [Google Scholar]
- 6. EURO ASPIRE Study Group : A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. European action on secondary prevention through intervention to reduce events. Eur Heart J 1997; 18: 1569–1582 [DOI] [PubMed] [Google Scholar]
- 7. EUROASPIRE II Study Group : Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: Principal results from EURO ASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554–572 [DOI] [PubMed] [Google Scholar]
- 8. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long‐term persistence in use of statin therapy in elderly patients. J Am Med Assoc 2002; 288: 455–461 [DOI] [PubMed] [Google Scholar]
- 9. Jackevicious C, Mamdani M, Tu J: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. J Am Med Assoc 2002; 288: 462–467 [DOI] [PubMed] [Google Scholar]
- 10. Fonarow G: Statin therapy after acute myocardial infarction: Are we adequately treating high‐risk patients? Curr Atheroscler Rep 2002; 4: 99–106 [DOI] [PubMed] [Google Scholar]
- 11. Hunninghake D: Postdischarge lipid management of coronary artery disease patients according to the new National Cholesterol Education Program guidelines. Am J Cardiol 2001; 88: 37K–41K [DOI] [PubMed] [Google Scholar]
- 12. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V: Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle‐aged men with dyslipidemia. Safety of treatment, changes in riskfactors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–1245 [DOI] [PubMed] [Google Scholar]
- 13. Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Friedlander T, Bushnell AC, Chandra‐Strobos N: Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 2003; 139 (12): 979–986 [DOI] [PubMed] [Google Scholar]
- 14. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301–1307 [DOI] [PubMed] [Google Scholar]
- 15. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high‐risk individuals : A randomized placebo‐controlled trial. Lancet 2002; 360: 7–22 [DOI] [PubMed] [Google Scholar]
- 16. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) : Final report. US Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute. Circulation 2002; 106: 31–43 [PubMed] [Google Scholar]
- 17. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1847 [DOI] [PubMed] [Google Scholar]
- 18. Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H: Scandinavian Simvastatin Survival Study Group. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med 1997; 336: 332–336 [DOI] [PubMed] [Google Scholar]